Submit

Lung Cancer News

Cancer Services and Community Health Coalition Both Receive $5,000 Access Grants

Cancer Services and Community Health Coalition Both Receive $5,000 Access Grants

  The Lung Cancer Initiative of North Carolina is pleased to announce Cancer Services and Community Health Coalition as the recipients of 5,000 Access Grants each.  The goal of the Access Grant Program is to partner with community organizations in North Carolina to improve access to care and

FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC

FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC

FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC – This Second Alecensa Breakthrough Therapy Designation Was Granted Based on Phase III J-ALEX Study  – SOUTH SAN FRANCISCO, Calif. – October 3, 2016

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

Press Release  FOR IMMEDIATE RELEASE ON SEPTEMBER 14, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 669-9531 cfrierson@lungcancerinitiativenc.org   10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally September 14,

Lay Patient Navigation - Tomma Hargraves

Lay Patient Navigation - Tomma Hargraves

Lay Patient Navigation - Tomma Hargraves Tomma Hargraves, lung cancer survivor and board secretary for the Lung Cancer Initiative of North Carolina, shares with us one of the many ways that she gets involved in helping others who have received a cancer diagnosis.  The Lay Patient Navigation

ASCO Update

ASCO Update

ASCO Update In June, the American Society of Clinical Oncology (ASCO) had their annual meeting in Chicago.  They are the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.  We were pleased to have Jenni Danai, our Senior Programs

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

Press Release  FOR IMMEDIATE RELEASE ON JUNE 11, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 784-0410 ext. 102 cfrierson@lungcancerinitiativenc.org   125,000 in Grants Awarded for Lung Cancer Research in North Carolina

$10,000 Grant Awarded to Improve Access to Lung Cancer Screening

$10,000 Grant Awarded to Improve Access to Lung Cancer Screening

Press Release  FOR IMMEDIATE RELEASE ON JUNE 28, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 784-0410 ext. 102 cfrierson@lungcancerinitiativenc.org   10,000 Grant Awarded to Improve Access to Lung Cancer Screening

Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib

Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib

Click here to read original article. Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib Comprehensive ELUXA trial program explores olmutinib (BI 1482694) as a monotherapy and in several combination studies

FDA Approves First Blood Test to Detect Gene Mutation Associated with Non-Small Cell Lung Cancer

FDA Approves First Blood Test to Detect Gene Mutation Associated with Non-Small Cell Lung Cancer

The original article can be found here. The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth

Garst Named To Top Cancer Doctors List

Garst Named To Top Cancer Doctors List

Original article is by Karen E. Butler and can be found here. Newsweek magazine online recently published the Castle Connolly Medical LTD list of “Top Cancer Doctors.” Medical oncologist Jennifer Garst, MD, professor of medicine, was among those named to the 2015 list. Garst, who practices at

GuideStar Gold Participant